Navigation Links
UCSF Medical Center Leads Nation in ER Heart Attack Care
Date:12/2/2008

UCSF Medical Center ranks No. 1 nationwide for the speed with which heart attack patients are treated using balloon angioplasty, according to the National Cardiovascular Data Registry (NCDR).

(Vocus) December 2, 2008 -- UCSF Medical Center ranks No. 1 nationwide for the speed with which heart attack patients are treated using balloon angioplasty, according to the National Cardiovascular Data Registry (NCDR). Cardiac balloon angioplasty and stenting are the procedures used to open narrowed or blocked blood vessels and must be performed quickly after a heart attack to minimize heart muscle loss.

Patients were treated by UCSF interventional cardiologists on average less than an hour - 56 minutes for the first quarter of 2008 and 52 minutes for the second - after arriving in the Emergency Department, considerably faster than the 90-minute benchmark set by NCDR.

UCSF was first among more than 850 hospitals participating in the survey, which accounted for a 12-month period ending June 2008. UCSF began reporting its treatment time to the NCDR in January 2007 and has led the nation since April 2007.

The NCDR, working in conjunction with the American College of Cardiology, compiles benchmarking data for cardiovascular patient care. In 2007, the average time reported by hospitals for balloon angioplasty - beginning when the patient enters the emergency room - was 118 minutes. Currently, the average time among all hospitals reporting is 106 minutes.

"This outstanding performance reflects the hard work of so many people in the Emergency Department and Cardiac Catheterization Lab," said Yerem Yeghiazarians, MD, interventional cardiologist and co-director of the UCSF Adult Cardiac Catheterization Laboratory. "Our focused team effort results in beneficial outcomes for our patients."

The American College of Cardiology initiated a nationwide campaign to improve to 90 minutes or less "door-to-balloon" time, the name given for the time spent between a patient's arrival at the hospital to the receipt of angioplasty surgery to unblock clogged arteries. The risk to patients increases with every minute delayed for treatment.

"Heart attacks range in severity according to whether arteries are totally or partially blocked," said Thomas Ports, MD, interventional cardiologist and co-director of the UCSF Adult Cardiac Catheterization Laboratory. "If arteries are fully blocked, mortality increases significantly every 30 minutes that a patient goes without treatment."

For the procedure, a catheter is inserted into a leg or arm artery and fed into the blocked artery around the heart. A balloon, connected to the catheter, is expanded to open the artery. Cardiologists then place a wire mesh tube, called a stent, at the area of blockage to keep the artery open.

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.

###

Read the full story at http://www.prweb.com/releases/Balloon_Angioplasty/ER_Heart_Attack_Care/prweb1697644.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Driving Consumer Engagement Is Focus of Address by Healthfitness Chief Medical Officer at Watson Wyatt Health Care Solutions Event
2. Medical-Billing.com to Revolutionize Electronic Medical Recordkeeping With National Patient Registry
3. Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its First Quarter Ended October 31, 2008
4. New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training
5. Revised hours and workloads for medical residents needed to prevent
6. Consumers Uncertain About Their Medical Diagnosis & Treatment
7. Response Biomedical Corporation Announces Initiation of Respiratory Syncytial Virus Infection Clinical Trial
8. Levaquin is the Preferred Quinolone Among More Than Half of All General Medical-Surgical Hospitals in the United States
9. China Sky One Medical, Inc. Appoints Yu-bo Hao as CFO
10. The National Health Service and Attainia Move to Modernize Medical Capital Equipment Budgeting and Planning for the United Kingdom
11. Encouraging Prospects for Medical Imaging Equipment Services in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UCSF Medical Center Leads Nation in ER Heart Attack Care
(Date:2/26/2017)... ... , ... IndustryArchive.Org . is announcing a new way for B2B Sellers ... only pay for B.A.N.T. quality sales leads based on the Sellers decision to purchase ... reality that B2B buyers are controlling the sales process via the Internet and that ...
(Date:2/26/2017)... ... , ... ODH, Inc.™ announced today it will exhibit and speak at ... Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present ... population health management. , ODH will also have an exhibit booth where attendees may ...
(Date:2/26/2017)... ... February 26, 2017 , ... Occupational pesticide exposure ... a specific LRRK2 mutation, according to a study released today at the 1st ... of a link between pesticides and incidence of sporadic PD through occupational exposure. ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... its newly designed TaskMate Go. Core benefits and advantages built into the home ... a stylish, functional look and feel. Ability to gain the benefits embedded in ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the ... Market (ILTM) show in Cannes (France), XO Private has initiated a second print-run of ... book measures almost a metre across when open, weighs in at more than six ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... ITL Limited, ( ASX : ITD ), une société de ... excellents résultats semestriels clos le 31 décembre 2016 par ... « Résultats et mise à jour sur la croissance biomédicale ... Faits marquants Bénéfice ... hausse de 104 %) Bénéfice par action ...
(Date:2/24/2017)... 2017 Non-alcoholic steatohepataitis (NASH) Pipeline ... drugs being developed for the treatment of ... that are in various phases of development ... on novel pharmacologic drugs & regenerative medicines ... recombinant proteins and RNA-based therapeutics, but excludes ...
(Date:2/24/2017)... Wyoming , Feb. 24, 2017  Xynomic Pharmaceuticals, ... today announced that it has acquired exclusive worldwide ... potentially best-in-class innovative HDAC inhibitor targeting hematological and ... of 14 Phase 1 and 2 clinical trials ... Asia have already been completed, demonstrating ...
Breaking Medicine Technology: